Publication | Closed Access

Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14)

Hematological MalignancyMedicineHematologyImmunologyPathologyMyeloma CellsCd56 ExpressionAdult T-cell Leukemia-lymphomaOncologyCancer ResearchTranslocation T